Company Filing History:

8 out of 72

Genelabs Technologies, Inc.

patents

1 out of 1,215

The United States of America As Represented by the Department of Health

patents

1 out of 3,439

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

4. 1 out of 254

The United States of America

patents

5. 2 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2006

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7094406 - Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof (2006-08-22),

2. 6455492 - Hepatitis E virus vaccine and method (2002-09-24),

3. 6379891 - Method of detecting HEV infection (2002-04-30),

4. 6291641 - Hepatitis E virus antigens and uses therefor (2001-09-18),

5. 6229005 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent (2001-05-08),

6. 6214970 - Hepatitis E virus antigens and uses therefor (2001-04-10),

7. 6120988 - Method of detecting hev infection (2000-09-19),

8. 5824649 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral (1998-10-20),

9. 5789559 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral (1998-08-04),

10. 5770689 - Hepatitis E virus ORF Z peptides (1998-06-23),

11. 5686239 - Hepatitis E virus peptides and methods (1997-11-11),

Title: The Innovative Contributions of Patrice O Yarbough

Introduction

Patrice O Yarbough is a prominent inventor based in Union City, CA, known for her significant contributions to the field of virology. With a total of 11 patents to her name, she has made remarkable advancements in the understanding and prevention of hepatitis E virus (HEV) infections. Her work has had a profound impact on diagnostic methods and vaccine development.

Latest Patents

Among her latest patents, Yarbough has developed a diagnostic method for detecting infection by the enterically transmitted non-A/non-B hepatitis viral agent. This patent discloses viral proteins derived from the hepatitis E virus, which are immunologically reactive with antibodies present in infected individuals. Additionally, she has identified specific epitopes that react with sera from individuals infected with different strains of HEV. Another notable patent focuses on an antigen and antibody vaccine composition effective in preventing HEV infection. This composition includes peptides that correspond to critical regions of the HEV genome and has shown effectiveness in preventing infection after vaccination.

Career Highlights

Throughout her career, Patrice O Yarbough has worked with various organizations, including Genelabs Technologies, Inc. Her innovative research has positioned her as a leader in the field of viral hepatitis, contributing to both scientific knowledge and public health.

Collaborations

Yarbough has collaborated with notable professionals in her field, including Gregory R Reyes and Albert W Tam. These collaborations have further enhanced her research and development efforts.

Conclusion

Patrice O Yarbough's contributions to the field of virology, particularly in the area of hepatitis E, highlight her role as an influential inventor. Her patents and research continue to pave the way for advancements in diagnostics and vaccine development, showcasing her dedication to improving public health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.